- Report
- March 2024
- 188 Pages
Global
From €3242EUR$3,374USD£2,772GBP
€3602EUR$3,749USD£3,080GBP
- Report
- November 2023
- 170 Pages
Global
From €5717EUR$5,950USD£4,888GBP
- Report
- February 2024
- 250 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- December 2023
- 200 Pages
Global
From €3843EUR$4,000USD£3,286GBP
- Report
- February 2024
- 183 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- February 2024
- 182 Pages
Global
From €2402EUR$2,500USD£2,054GBP
- Report
- September 2020
- 700 Pages
Global
From €4708EUR$4,900USD£4,025GBP
- Report
- May 2020
- 114 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- June 2019
- 374 Pages
Global
From €3891EUR$4,050USD£3,327GBP
- Book
- April 2022
- 432 Pages
- Book
- January 2022
- 720 Pages
- Book
- October 2020
- 3632 Pages
- Book
- January 2018
- 904 Pages
- Book
- December 2013
- 328 Pages
Tissue engineering biomaterials are materials used to create artificial tissues and organs for medical purposes. These materials are used to replace or regenerate damaged or diseased tissues and organs. They are typically composed of biocompatible polymers, ceramics, metals, and other materials. The biomaterials are designed to interact with the body in a way that promotes tissue regeneration and healing.
The tissue engineering biomaterials market is a rapidly growing segment of the biotechnology industry. It is driven by the increasing demand for tissue replacement and regeneration therapies, as well as advances in materials science and biotechnology. The market is expected to continue to grow as new technologies and materials are developed.
Some of the major companies in the tissue engineering biomaterials market include Corbion, DSM, Evonik, Merck KGaA, and PolyOne. Show Less Read more